PTI| Canberra | Australia
Australia's Therapeutic Goods Administration has given provisional approval to the drug remdesivir, an experimental medicine that has shown promise in the recovery time of the most seriously ill COVID-19 patients. The approval comes as Australia is seeing a sharp increase in coronavirus infections in the state of Victoria, which reported a record 288 new confirmed cases Friday.
Authorities say remdesivir will be available only to patients who are severely ill, require oxygen or high-level support to breathe, and are in hospital care. It is the only drug licensed by both the US and the European Union as a treatment for people with severe illness from the coronavirus. With a population of 26 million, Australia has recorded more than 9,000 coronavirus cases, with 106 deaths.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
{{#Source}}{{Source}}{{/Source}}{{#IsBlog}}
{{Disclaimer}}
{{/Disclaimer}}